<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font6" size="8" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font7" size="8" family="GillSans" color="#000000"/>
<text top="41" left="55" width="48" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title"><i>CytoJournal</i></text>
<text top="41" left="103" width="28" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="0" tag_type="title"> 2005, </text>
<text top="41" left="131" width="5" height="10" font="font2" id="p1_t3" reading_order_no="2" segment_no="0" tag_type="title"><b>2</b></text>
<text top="41" left="136" width="12" height="10" font="font1" id="p1_t4" reading_order_no="3" segment_no="0" tag_type="title">:14</text>
<text top="41" left="387" width="167" height="10" font="font1" id="p1_t5" reading_order_no="4" segment_no="1" tag_type="text">http://www.cytojournal.com/content/2/1/14</text>
<text top="756" left="508" width="46" height="10" font="font1" id="p1_t6" reading_order_no="106" segment_no="12" tag_type="text">Page 3 of 6</text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t7" reading_order_no="107" segment_no="13" tag_type="text"><i>(page number not for citation purposes)</i></text>
<text top="239" left="55" width="241" height="9" font="font4" id="p1_t8" reading_order_no="27" segment_no="5" tag_type="text">All 85 aspirates were obtained on palpable lymph nodes</text>
<text top="251" left="55" width="241" height="9" font="font4" id="p1_t9" reading_order_no="28" segment_no="5" tag_type="text">by cytopathologists using 25 to 27 gauge needles. Aspi-</text>
<text top="263" left="55" width="241" height="9" font="font4" id="p1_t10" reading_order_no="29" segment_no="5" tag_type="text">rated material was immediately smeared on slides, air-</text>
<text top="275" left="55" width="241" height="9" font="font4" id="p1_t11" reading_order_no="30" segment_no="5" tag_type="text">dried, and stained with Diff-Quik and ultra-fast Papanico-</text>
<text top="286" left="55" width="241" height="9" font="font4" id="p1_t12" reading_order_no="31" segment_no="5" tag_type="text">laou stains. Additional material obtained for FCM was</text>
<text top="298" left="55" width="241" height="9" font="font4" id="p1_t13" reading_order_no="32" segment_no="5" tag_type="text">placed in RPMI solution. The cytologic diagnoses were</text>
<text top="310" left="55" width="241" height="9" font="font4" id="p1_t14" reading_order_no="33" segment_no="5" tag_type="text">grouped into four categories: reactive, atypical, HL, and</text>
<text top="322" left="55" width="241" height="9" font="font4" id="p1_t15" reading_order_no="34" segment_no="5" tag_type="text">NHL. Histologic follow-up was available in 17/85 (20%)</text>
<text top="333" left="55" width="51" height="9" font="font4" id="p1_t16" reading_order_no="35" segment_no="5" tag_type="text">of the cases.</text>
<text top="357" left="55" width="241" height="9" font="font4" id="p1_t17" reading_order_no="36" segment_no="7" tag_type="text">Flow cytometric studies were performed using FACscan</text>
<text top="369" left="55" width="241" height="9" font="font4" id="p1_t18" reading_order_no="37" segment_no="7" tag_type="text">flow cytometer (Becton Dickinson, San Jose, CA). The</text>
<text top="380" left="55" width="241" height="9" font="font4" id="p1_t19" reading_order_no="38" segment_no="7" tag_type="text">specimens, suspended in RPMI solution, were centrifuged</text>
<text top="392" left="55" width="241" height="9" font="font4" id="p1_t20" reading_order_no="39" segment_no="7" tag_type="text">at 1500 rpm for 5 minutes, the supernatant was discarded,</text>
<text top="404" left="55" width="241" height="9" font="font4" id="p1_t21" reading_order_no="40" segment_no="7" tag_type="text">and red blood cells were lysed using Becton Dickinson</text>
<text top="416" left="55" width="241" height="9" font="font4" id="p1_t22" reading_order_no="41" segment_no="7" tag_type="text">FACS Lysing Solution. The cell pellets were then washed</text>
<text top="427" left="55" width="241" height="9" font="font4" id="p1_t23" reading_order_no="42" segment_no="7" tag_type="text">and resuspended in phosphate buffered saline. Aliquots</text>
<text top="439" left="55" width="241" height="9" font="font4" id="p1_t24" reading_order_no="43" segment_no="7" tag_type="text">of the cell suspension were then incubated with different</text>
<text top="451" left="55" width="241" height="9" font="font4" id="p1_t25" reading_order_no="44" segment_no="7" tag_type="text">combinations of monoclonal antibodies (three or four in</text>
<text top="463" left="55" width="241" height="9" font="font4" id="p1_t26" reading_order_no="45" segment_no="7" tag_type="text">each tube) including CD2, CD3, CD4, CD5, CD7, CD8,</text>
<text top="474" left="55" width="241" height="9" font="font4" id="p1_t27" reading_order_no="46" segment_no="7" tag_type="text">CD10, CD19, CD20, CD23, HLA-DR, and Kappa/Lambda</text>
<text top="486" left="55" width="241" height="9" font="font4" id="p1_t28" reading_order_no="47" segment_no="7" tag_type="text">light chain (all antibodies from Becton Dickinson, San</text>
<text top="498" left="55" width="241" height="9" font="font4" id="p1_t29" reading_order_no="48" segment_no="7" tag_type="text">Jose, CA). An average of 10000 lymphocytes was collected</text>
<text top="510" left="55" width="226" height="9" font="font4" id="p1_t30" reading_order_no="49" segment_no="7" tag_type="text">in the lymphocyte gate using forward and side scatter.</text>
<text top="533" left="55" width="36" height="10" font="font5" id="p1_t31" reading_order_no="50" segment_no="9" tag_type="title"><b>Results</b></text>
<text top="545" left="55" width="241" height="9" font="font4" id="p1_t32" reading_order_no="51" segment_no="10" tag_type="text">As shown<a href=""> in Table 1, th</a>e 85 lymph node aspirates were</text>
<text top="557" left="55" width="241" height="9" font="font4" id="p1_t33" reading_order_no="52" segment_no="10" tag_type="text">obtained from 85 patients ranging in age from 19 to 87</text>
<text top="568" left="55" width="241" height="9" font="font4" id="p1_t34" reading_order_no="53" segment_no="10" tag_type="text">years. 29 patients were male and 56 were female. Eleven</text>
<text top="580" left="55" width="241" height="9" font="font4" id="p1_t35" reading_order_no="54" segment_no="10" tag_type="text">patients had a previous diagnosis of a lymphoproliferative</text>
<text top="592" left="55" width="241" height="9" font="font4" id="p1_t36" reading_order_no="55" segment_no="10" tag_type="text">disorder (1 HL, 6 mycosis fungoides, 2 NHL, 1 acute lym-</text>
<text top="604" left="55" width="241" height="9" font="font4" id="p1_t37" reading_order_no="56" segment_no="10" tag_type="text">phoblastic leukemia, 1 Castleman disease). Lymph node</text>
<text top="615" left="55" width="241" height="9" font="font4" id="p1_t38" reading_order_no="57" segment_no="10" tag_type="text">sites were as follows: 14 inguinal, 43 cervical, 15 axillary,</text>
<text top="627" left="55" width="241" height="9" font="font4" id="p1_t39" reading_order_no="58" segment_no="10" tag_type="text">2 epitrochlear, 5 submental, 2 subauricular, 2 intra-</text>
<text top="639" left="55" width="241" height="9" font="font4" id="p1_t40" reading_order_no="59" segment_no="10" tag_type="text">parotid, 1 occipital, and 1 mediastinal. The lymph nodes</text>
<text top="651" left="55" width="241" height="9" font="font4" id="p1_t41" reading_order_no="60" segment_no="10" tag_type="text">ranged in diameter from 0.5 to 5 cm. CD4/CD8 T cell</text>
<text top="662" left="55" width="241" height="9" font="font4" id="p1_t42" reading_order_no="61" segment_no="10" tag_type="text">ratios ranged from 4 to 29. A CD4/CD8 T-cell ratio of 4</text>
<text top="674" left="55" width="241" height="9" font="font4" id="p1_t43" reading_order_no="62" segment_no="10" tag_type="text">was chosen as the cut-off point because it represents twice</text>
<text top="686" left="55" width="241" height="9" font="font4" id="p1_t44" reading_order_no="63" segment_no="10" tag_type="text">the normal value (2), and a cut-off point of 3.9 was shown</text>
<text top="698" left="55" width="241" height="9" font="font4" id="p1_t45" reading_order_no="64" segment_no="10" tag_type="text">to represent the lower limit of CD4/CD8 ratio is cases of</text>
<text top="709" left="55" width="162" height="9" font="font4" id="p1_t46" reading_order_no="65" segment_no="10" tag_type="text">HL in a recently published repo<a href="">rt [13]</a>.</text>
<text top="239" left="313" width="241" height="9" font="font4" id="p1_t47" reading_order_no="66" segment_no="6" tag_type="text">Overall, 64/85 (75%) lymph node aspirates were read as</text>
<text top="251" left="313" width="241" height="9" font="font4" id="p1_t48" reading_order_no="67" segment_no="6" tag_type="text">reactive on cytomorp<a href="">hology (Table 2). Th</a>e cytologic find-</text>
<text top="263" left="313" width="241" height="9" font="font4" id="p1_t49" reading_order_no="68" segment_no="6" tag_type="text">ings in these cases consisted of a heterogeneous popula-</text>
<text top="275" left="313" width="241" height="9" font="font4" id="p1_t50" reading_order_no="69" segment_no="6" tag_type="text">tion of small and large lymphocytes with no cytologic</text>
<text top="286" left="313" width="241" height="9" font="font4" id="p1_t51" reading_order_no="70" segment_no="6" tag_type="text">atypicality mixed with tingible body macrophages with</text>
<text top="298" left="313" width="241" height="9" font="font4" id="p1_t52" reading_order_no="71" segment_no="6" tag_type="text">no definitive R-S cells or variant<a href="">s (Figure 1)</a>. 5 of the 64</text>
<text top="310" left="313" width="241" height="9" font="font4" id="p1_t53" reading_order_no="72" segment_no="6" tag_type="text">reactive cases in which cytomorphology and FCM did not</text>
<text top="322" left="313" width="241" height="9" font="font4" id="p1_t54" reading_order_no="73" segment_no="6" tag_type="text">reveal evidence of a lymphoproliferative disorder had tis-</text>
<text top="333" left="313" width="241" height="9" font="font4" id="p1_t55" reading_order_no="74" segment_no="6" tag_type="text">sue follow-up because of persistent lymphadenopathy</text>
<text top="345" left="313" width="241" height="9" font="font4" id="p1_t56" reading_order_no="75" segment_no="6" tag_type="text">and high clinical suspicion. 3/5 cases (60%) confirmed</text>
<text top="357" left="313" width="184" height="9" font="font4" id="p1_t57" reading_order_no="76" segment_no="6" tag_type="text">the diagnosis of reactive lymphadenopathy.</text>
<text top="380" left="313" width="241" height="9" font="font4" id="p1_t58" reading_order_no="77" segment_no="8" tag_type="text">The two remaining cases (40%) were positive for lym-</text>
<text top="392" left="313" width="241" height="9" font="font4" id="p1_t59" reading_order_no="78" segment_no="8" tag_type="text">phoma. The first was diagnosed as nodular lymphocyte</text>
<text top="404" left="313" width="241" height="9" font="font4" id="p1_t60" reading_order_no="79" segment_no="8" tag_type="text">predominant Hodgkin lymphoma. Histologic evaluation</text>
<text top="416" left="313" width="241" height="9" font="font4" id="p1_t61" reading_order_no="80" segment_no="8" tag_type="text">revealed focal effacement of the nodal architecture by</text>
<text top="427" left="313" width="241" height="9" font="font4" id="p1_t62" reading_order_no="81" segment_no="8" tag_type="text">vague nodules of small lymphocytes admixed with occa-</text>
<text top="439" left="313" width="241" height="9" font="font4" id="p1_t63" reading_order_no="82" segment_no="8" tag_type="text">sional large atypical cells. Immunohistochemical stains</text>
<text top="451" left="313" width="241" height="9" font="font4" id="p1_t64" reading_order_no="83" segment_no="8" tag_type="text">performed on snap-frozen tissue showed that the small</text>
<text top="463" left="313" width="241" height="9" font="font4" id="p1_t65" reading_order_no="84" segment_no="8" tag_type="text">cells were mostly B-lymphocytes. The large atypical cells</text>
<text top="474" left="313" width="241" height="9" font="font4" id="p1_t66" reading_order_no="85" segment_no="8" tag_type="text">were positive for LCA, CD20 and EMA, and negative for</text>
<text top="486" left="313" width="241" height="9" font="font4" id="p1_t67" reading_order_no="86" segment_no="8" tag_type="text">CD15 and CD30. CD57 positive lymphocytes formed</text>
<text top="498" left="313" width="241" height="9" font="font4" id="p1_t68" reading_order_no="87" segment_no="8" tag_type="text">rosettes around the large cells. The second case was diag-</text>
<text top="510" left="313" width="241" height="9" font="font4" id="p1_t69" reading_order_no="88" segment_no="8" tag_type="text">nosed as peripheral T cell lymphoma. The patient had a</text>
<text top="521" left="313" width="241" height="9" font="font4" id="p1_t70" reading_order_no="89" segment_no="8" tag_type="text">history of breast cancer treated by chemotherapy and radi-</text>
<text top="533" left="313" width="241" height="9" font="font4" id="p1_t71" reading_order_no="90" segment_no="8" tag_type="text">ation. The lymph node was enlarged due to an expansion</text>
<text top="545" left="313" width="241" height="9" font="font4" id="p1_t72" reading_order_no="91" segment_no="8" tag_type="text">of the interfollicular area by medium-sized atypical lym-</text>
<text top="557" left="313" width="241" height="9" font="font4" id="p1_t73" reading_order_no="92" segment_no="8" tag_type="text">phocytes and increased vascularity with no significant</text>
<text top="568" left="313" width="241" height="9" font="font4" id="p1_t74" reading_order_no="93" segment_no="8" tag_type="text">increase in large cells. Immunohistochemistry confirmed</text>
<text top="580" left="313" width="241" height="9" font="font4" id="p1_t75" reading_order_no="94" segment_no="8" tag_type="text">that the atypical cells were CD3 and CD4 positive. CD8</text>
<text top="592" left="313" width="241" height="9" font="font4" id="p1_t76" reading_order_no="95" segment_no="8" tag_type="text">positive T cells represented a minority of the cells. Flow</text>
<text top="604" left="313" width="241" height="9" font="font4" id="p1_t77" reading_order_no="96" segment_no="8" tag_type="text">cytometry failed to diagnose this case because a limited</text>
<text top="615" left="313" width="241" height="9" font="font4" id="p1_t78" reading_order_no="97" segment_no="8" tag_type="text">panel of antibodies against T-cell surface markers was</text>
<text top="627" left="313" width="241" height="9" font="font4" id="p1_t79" reading_order_no="98" segment_no="8" tag_type="text">used. The increased CD4/CD8 ratio (4.20) was thought to</text>
<text top="639" left="313" width="241" height="9" font="font4" id="p1_t80" reading_order_no="99" segment_no="8" tag_type="text">be a reactive change secondary to chemotherapy for breast</text>
<text top="651" left="313" width="29" height="9" font="font4" id="p1_t81" reading_order_no="100" segment_no="8" tag_type="text">cancer.</text>
<text top="674" left="313" width="241" height="9" font="font4" id="p1_t82" reading_order_no="101" segment_no="11" tag_type="text">15 out of 85 cases were read as atypical. These cases con-</text>
<text top="686" left="313" width="241" height="9" font="font4" id="p1_t83" reading_order_no="102" segment_no="11" tag_type="text">sisted mostly of a heterogeneous population of small lym-</text>
<text top="698" left="313" width="241" height="9" font="font4" id="p1_t84" reading_order_no="103" segment_no="11" tag_type="text">phocytes admixed with a population of intermediate or</text>
<text top="709" left="313" width="241" height="9" font="font4" id="p1_t85" reading_order_no="104" segment_no="11" tag_type="text">large cells, some showing angulated nuclei and prominent</text>
<text top="721" left="313" width="241" height="9" font="font4" id="p1_t86" reading_order_no="105" segment_no="11" tag_type="text">nucleoli with no definitive R-S cells or variants. 8/15 cases</text>
<text top="87" left="55" width="209" height="7" font="font6" id="p1_t87" reading_order_no="5" segment_no="2" tag_type="title"><b>Table 2: Summary of cytologic and histologic evaluation</b></text>
<text top="105" left="59" width="50" height="7" font="font7" id="p1_t88" reading_order_no="6" segment_no="3" tag_type="table">FNA Diagnosis</text>
<text top="105" left="184" width="47" height="7" font="font7" id="p1_t89" reading_order_no="7" segment_no="3" tag_type="table"># of cases (%)</text>
<text top="105" left="309" width="57" height="7" font="font7" id="p1_t90" reading_order_no="8" segment_no="3" tag_type="table">Biopsy Follow up</text>
<text top="105" left="433" width="35" height="7" font="font7" id="p1_t91" reading_order_no="9" segment_no="3" tag_type="table">CD4/CD8</text>
<text top="127" left="59" width="28" height="7" font="font7" id="p1_t92" reading_order_no="10" segment_no="3" tag_type="table">Reactive</text>
<text top="127" left="184" width="30" height="7" font="font7" id="p1_t93" reading_order_no="11" segment_no="3" tag_type="table">64 (75%)</text>
<text top="127" left="308" width="64" height="7" font="font7" id="p1_t94" reading_order_no="12" segment_no="3" tag_type="table">5 (3R, 1HL, 1NHL)</text>
<text top="127" left="433" width="40" height="7" font="font7" id="p1_t95" reading_order_no="13" segment_no="3" tag_type="table">4.1–29 (7.5)</text>
<text top="137" left="59" width="27" height="7" font="font7" id="p1_t96" reading_order_no="14" segment_no="3" tag_type="table">Atypical</text>
<text top="137" left="184" width="30" height="7" font="font7" id="p1_t97" reading_order_no="15" segment_no="3" tag_type="table">15 (18%)</text>
<text top="137" left="309" width="64" height="7" font="font7" id="p1_t98" reading_order_no="16" segment_no="3" tag_type="table">8 (1R, 3HL, 4NHL)</text>
<text top="137" left="433" width="40" height="7" font="font7" id="p1_t99" reading_order_no="17" segment_no="3" tag_type="table">4.6–14 (7.9)</text>
<text top="148" left="59" width="10" height="7" font="font7" id="p1_t100" reading_order_no="18" segment_no="3" tag_type="table">HL</text>
<text top="148" left="184" width="21" height="7" font="font7" id="p1_t101" reading_order_no="19" segment_no="3" tag_type="table">4 (5%)</text>
<text top="148" left="309" width="26" height="7" font="font7" id="p1_t102" reading_order_no="20" segment_no="3" tag_type="table">3 (3HL)</text>
<text top="148" left="433" width="40" height="7" font="font7" id="p1_t103" reading_order_no="21" segment_no="3" tag_type="table">5.3–13 (7.4)</text>
<text top="158" left="59" width="16" height="7" font="font7" id="p1_t104" reading_order_no="22" segment_no="3" tag_type="table">NHL</text>
<text top="158" left="184" width="21" height="7" font="font7" id="p1_t105" reading_order_no="23" segment_no="3" tag_type="table">2 (2%)</text>
<text top="158" left="309" width="23" height="7" font="font7" id="p1_t106" reading_order_no="24" segment_no="3" tag_type="table">1 NHL</text>
<text top="158" left="433" width="36" height="7" font="font7" id="p1_t107" reading_order_no="25" segment_no="3" tag_type="table">4–5.6 (4.8)</text>
<text top="180" left="59" width="432" height="7" font="font7" id="p1_t108" reading_order_no="26" segment_no="4" tag_type="text">FNA: fine needle aspiration; R: reactive; HL: Hodgkin lymphoma; NHL: non-Hodgkin lymphoma. CD4/CD8 ratio range and mean.</text>
</page>
</pdf2xml>
